\n<\/p>\n
CAIRO,
When India experienced an
Six shipments of Remdesivir
“I’m glad to say that the six
EVA Pharma is the only company
COVID-19 cases in India have
“We are proud to support
The\u00a0success of the
“As developing
CAIRO,
EGYPT – EQS Newswire – 27 July 2021 – EVA Pharma’s (www.EVAPharma.com) timely shipments of Remdesivir reached India during a major
wave of coronavirus cases.
When India experienced an
unexpected COVID-19 surge this spring, the rapid increase in cases put pressure
on the local pharmaceutical industry to supply the medicines needed. In …<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[60],"tags":[],"_links":{"self":[{"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/posts\/16561"}],"collection":[{"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/comments?post=16561"}],"version-history":[{"count":0,"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/posts\/16561\/revisions"}],"wp:attachment":[{"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/media?parent=16561"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/categories?post=16561"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/tags?post=16561"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nEGYPT – EQS Newswire – 27 July 2021 – EVA Pharma’s (www.EVAPharma.com<\/a>) timely shipments of Remdesivir reached India during a major
\nwave of coronavirus cases.<\/p>\n
\n
<\/p>\n
\nunexpected COVID-19 surge this spring, the rapid increase in cases put pressure
\non the local pharmaceutical industry to supply the medicines needed. In April,
\nEVA Pharma signed a contract with the Indian government to export 300,000 vials
\nof Remdesivir, an approved treatment for coronavirus, to meet the urgent needs
\nthere.<\/p>\n
\n
<\/p>\n
\nwere flown to Mumbai between May and June and were subsequently dispatched to
\nhospitals across India, reaching patients everywhere from major cities to the
\nremote archipelago of Lakshadweep.<\/p>\n
\n
<\/p>\n
\nconsignments in which the Remdesivir was dispatched to India were not only sent
\non schedule but in all cases before the schedule,” commented Ambassador Ajit
\nGupte, India’s envoy to Egypt. “This was a period when the caseload was very
\nhigh in India, and the shipments would have helped to save a lot of
\nlives.”\u00a0<\/p>\n
\n
<\/p>\n
\nin the Middle East or Africa that has been granted a voluntary license to produce
\nand distribute Remdesivir by Gilead Sciences, Inc, the owner of the molecule.
\nThe production lines at the EVA Pharma facility in Haram, Cairo, are certified
\nby the European Medicines Agency (EMA), enabling the company to export its
\nproducts globally.\u00a0<\/p>\n
\n
<\/p>\n
\nsince declined, reducing the immediate pressure on local health systems and
\nsupply lines. Cases in other countries have gone up in recent months, however,
\nespecially due to the spread of the Delta variant. As a result, EVA Pharma has
\nincreased its exports of Remdesivir to other Asian countries such as
\nIndonesia.<\/p>\n
\n
<\/p>\n
\nCOVID-19 efforts both in Egypt and around the world by manufacturing Remdesivir
\nat our world-class manufacturing facility in Cairo,” said Dr. Riad Armanious,
\nCEO of EVA Pharma. “With our monthly production of Remdesivir now amounting to
\n1.5 million doses, we are able to meet the local needs of Egyptian patients
\nwhile also helping other countries tackle this crisis. In fact, we now supply
\nmore than 20 countries around the world with Remdesivir.”<\/p>\n
\n
<\/p>\n
\ncooperation between EVA Pharma and India\u00a0highlights\u00a0the potential for
\nfurther\u00a0fruitful\u00a0collaboration\u00a0between emerging economies,
\nespecially during times of need.<\/p>\n
\n
<\/p>\n
\ncountries, what I can say is India and Egypt face similar challenges,” said
\nAmbassador Gupte. “One of the challenges we face is how we can provide
\naffordable health care to our millions of people because we are populous
\ncountries. Cost is important. So I think the closer the cooperation between
\nIndia and Egypt, the more we will be able to help provide basic needs for the
\npeople of our countries.”\u00a0<\/p>\n<\/p><\/div>\n\n
Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"